Ferrow Pfanstiehl Laboratories: Pfanstiehl Announces New Histidine Products for Biopharmaceutical Formulations
Pfanstiehl announced that it has launched high purity, low endotoxin, low metal L-histidine and L-histidine hydrochloride monohydrate for a new quality standard for amino acids. Suitable for bioprocessing, solubilization, and stabilization applications, the new histidine products allow for
Read full article »
Pfanstiehl is an Illinois-based biotechnology firm that produces and supplies cGMP-produced, injectable-grade excipients and bioprocessing solutions for the healthcare sector.
Read more